Advertisement

Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy

Published:January 16, 2020DOI:https://doi.org/10.1016/j.ejim.2019.12.016

      Highlights

      • The study aim was to assess the risk for in-hospital death after confirmed ICH.
      • Patients with ICH were on antiplatelets, VKAs, DOACs or no antithrombotic agents.
      • In-hospital death is associated with GCS, age, previous stroke and hematoma volume.
      • Preceding treatment with antithrombotic is associated with the severity of ICH.

      Abstract

      The association between preceding treatment with antiplatelet agents (APs), vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) and mortality after intracerebral hemorrhage (ICH) remains unclear.
      The aim of this multicenter, prospective cohort study was to assess the risk for death after ICH in consecutive patients who were on treatment with APs, VKAs, DOACs, or no antithrombotic agent. The primary outcome was in-hospital death by day 30. ICH volume at admission and volume expansion were centrally assessed.
      Out of 598 study patients, in-hospital death occurred in 21% of patients who were on treatment with APs, 25% with VKAs, 30% with DOACs, and 13% with no antithrombotics. Crude death rate was higher in patients on antithrombotics as compared to patients receiving no antithrombotic agent. At multivariate analysis, age (HR 1.07; 95% CI 1.04–1.10), previous stroke (HR 1.83; 95% CI 1.14–2.93), GCS ≤8 at admission (HR 6.06; 95% CI 3.16–9.74) and GCS 9–12 (HR 3.38; 95% CI 1.81–6.33) were independent predictors of death. Treatment with APs (HR 1.29; 95% CI 0.61–2.76), VKAs (HR 1.42; 95% CI 0.70–2.88) or DOACs (HR 1.28; 95% CI 0.61–2.73) were not predictors of death in the overall study population, in non-trauma associated ICH as well as when GCS was not included in the model. ICH volume and volume expansion were independent predictors of death.
      In conclusion, preceding treatment with antithrombotic is associated with the severity of ICH. Age, previous stroke and clinical severity at presentation were independent predictors of in-hospital death in patients with ICH.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Feigin V.L.
        • Lawes C.M.M.
        • Bennett D.A.
        • Anderson C.S.
        Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.
        Lancet Neurol. 2003; 2: 43-53
        • Weimar C.
        • Weber C.
        • Wagner M.
        • et al.
        Management patterns and health care use after intracerebral hemorrhage. a cost-of-illness study from a societal perspective in Germany.
        Cerebrovasc Dis. 2003; 15: 29-36
        • Flaherty M.L.
        • Haverbusch M.
        • Sekar P.
        • et al.
        Long-term mortality after intracerebral hemorrhage.
        Neurology. 2006; 25 (66): 1182-1186
        • Fogelholm R.
        • Murros K.
        • Rissanen A.
        • Avikainen S.
        Long term survival after primary intracerebral haemorrhage: a retrospective population based study.
        J Neurol Neurosurg Psychiatry. 2005; 76: 1534-1538
        • Hemphill III, J.C.
        • Bonovich D.C.
        • Besmertis L.
        • Manley G.T.
        • Johnston S.C.
        The ICH score: a simple, reliable grading scale for intracerebral hemorrhage.
        Stroke. 2001; 32: 891-897
        • Specogna A.V.
        • Turin T.C.
        • Patten S.B.
        • Hill M.D.
        Factors associated with early deterioration after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis.
        PLoS ONE. 2014; 9: e96743
        • Poon M.T.
        • Fonville A.F.
        • Al-Shahi Salman R.
        Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis.
        J Neurol Neurosurg Psychiatry. 2014; 85: 660-667
        • Steiner T.
        • Bosel J.
        Option to restrict hematoma expansion after spontaneous intracerebral haemorrhage.
        Stroke. 2010; 41: 402-409
        • Brouwers H.B.
        • Greengerg S.M.
        Hematoma expansion following acute intracerebral haemorrhage.
        Cerebrovasc Dis. 2013; 35: 195-201
        • Broderick J.P.
        • Brott T.G.
        • Duldner J.E.
        • et al.
        Volume of intracerebral haemorrhage. a powerful andeasy-to-use predictor of 30-day mortality.
        Stroke. 1993; 24: 987-993
        • Esfahani D.R.
        • Radnis C.A.
        • Hussein A.E.
        • Amin-Hanjani S.
        • Charbel F.T.
        • Alaraj A.
        Thresholds for volume and expansion in intraparenchymal hemorrhage: predictors of neurologic deterioration and mortality.
        World Neurosurg. 2017; 106: 131-138
        • Inohara T.
        • Xian Y.
        • Liang L.
        • et al.
        Association of intracerebral hemorrhage among patients taking non-vitamin k antagonist vs vitamin k antagonist oral anticoagulants with in-hospital mortality.
        JAMA. 2018; 319: 463-473
        • Al-Shahi Salman R.
        • Frantzias J.
        • Lee R.J.
        • et al.
        VISTA-ICH collaboration; ICH growth individual patient data meta-analysis collaborators. absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.
        Lancet Neurol. 2018; 17: 885-894
        • Toyoda K.
        • Okada Y.
        • Minematsu K.
        • et al.
        Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.
        Neurology. 2005; 65: 1000-1004
        • Roquer J.
        • Rodriguez Campello A.
        • Gomis M.
        • et al.
        Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage.
        J Neurol. 2005; 252: 412-416
        • Saloheimo P.
        • Ahonen M.
        • Juvela S.
        • et al.
        Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death.
        Stroke. 2006; 37: 129-133
        • Foerch C.
        • Sitzer M.
        • Steinmetz H.
        • et al.
        Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage.
        Stroke. 2006; 37: 2165-2167
        • Caso V.
        • Paciaroni M.
        • Venti M.
        • et al.
        Effect of on admission antiplatelet treatment on patients with cerebral hemorrhage.
        Cerebrovasc Dis. 2007; 24: 215-218
        • Roquer J.
        • Vivanco Hidalgo R.M.
        • Ois A.
        • et al.
        Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage.
        Neurology. 2017; 88: 885-891
        • Thompson B.B.
        • Béjot Y.
        • Caso V.
        • et al.
        Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review.
        Neurology. 2010; 75: 1333-1342
        • Franke C.L.
        • de Jonge J.
        • van Swieten J.C.
        • Op de Coul A.A.
        • van Gijn J.
        Intracerebral hematomas during anticoagulant treatment.
        Stroke. 1990; 21: 726-730
        • Hart R.G.
        • Boop B.S.
        • Anderson D.C.
        Oral anticoagulants and intracranial hemorrhage: facts and hypotheses.
        Stroke. 1995; 26: 1471-1477
        • Punthkee X.
        • Doobay J.
        • Annd S.S.
        Oral-anticoagulation related intracerebral hemorrhage.
        Thromb Res. 2002; 108: 31-36
        • Cucchiara B.
        • Messe S.
        • Sansing L.
        • et al.
        For the chant investigators. hematoma growth in oral anticoagulant related intracerebral hemorrhage.
        Stroke. 2008; 39: 2993-2996
        • Berwaerts J.
        • Dijkhuizen R.S.
        • Robb O.J.
        • et al.
        Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral haemorrhage.
        Stroke. 2000; 31: 2558-2562
        • Flibotte J.J.
        • Hagan N.
        • O'Donnel J.
        • et al.
        Warfarin, hematoma expansion, and outcome of intracerebral haemorrhage.
        Neurology. 2004; 63: 1059-1064
        • Flaherty M.L.
        • Tao H.
        • Haverbusch M.
        • et al.
        Warfarin use leads to larger intracerebral hematomas.
        Neurology. 2008; 71: 1084-1089
        • Connolly S.J.
        • Ezekowitz M.D.
        • Yusuf S.
        • et al.
        Dabigatran versus warfarin in patients with atrial fibrillation.
        N Engl J Med. 2009; 361: 1139-1151
        • Granger C.B.
        • Alexander J.H.
        • McMurray J.J.V.
        • et al.
        Apixaban versus warfarin in patients with atrial fibrillation.
        N Engl J Med. 2011; 365: 981-992
        • Patel M.R.
        • Mahaffey K.W.
        • Garg J.
        • et al.
        Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
        N Engl J Med. 2011; 365: 883-891
        • Yasaka M.
        New insights into nonvitamin k antagonist oral anticoagulants’ reversal of intracerebral hemorrhage.
        Front Neurol Neurosci. 2015; 37: 93-106
        • Tsivgoulis G.
        • Lioutas V.A.
        • Varelas P.
        • et al.
        Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
        Neurology. 2017; 89: 1142-1151
        • Takahashi H.
        • Jimbo Y.
        • Takano H.
        • et al.
        Intracerebral hematoma occurring during warfarin versus non-vitamin k antagonist oral anticoagulant therapy.
        Am J Cardiol. 2016; 118: 222-225
        • Adachi T.
        • Hoshino H.
        • Takagi M.
        • et al.
        Volume and characteristics of intracerebral hemorrhage with direct oral anticoagulants in comparison with warfarin.
        Cerebrovasc Dis Extra. 2017; 7: 62-71
        • Marques-Matos C.
        • Alves J.N.
        • Marto J.P.
        • et al.
        POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants.
        Int J Stroke. 2017; 12: 623-627
        • Boulouis G.
        • Morotti A.
        • Pasi M.
        • Goldstein J.N.
        • Gurol M.E.
        • Charidimou A.
        Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
        J Neurol Neurosurg Psychiatry. 2018; 89: 263-270
        • Beynon C.
        • Sakowitz O.W.
        • Störzinger D.
        • et al.
        Intracranial haemorrhage in patients treated with direct oral anticoagulants.
        Thromb Res. 2015; 136: 560-565
        • Alonso A.
        • Bengtson L.G.
        • MacLehose R.F.
        • et al.
        Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin.
        Stroke. 2014; 45: 2286-2291
        • Hagii J.
        • Tomita H.
        • Metoki N.
        • et al.
        Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin.
        Stroke. 2014; 45: 2805-2807
        • Wilson D.
        • Seiffge D.J.
        • Traenka C.
        • et al.
        Outcome of intracerebral hemorrhage associated with different oral anticoagulants.
        Neurology. 2017; 88: 1693-1700
        • von der Brelie C.
        • Doukas A.
        • Naumann R.
        • et al.
        Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants.
        Acta Neurochir. 2017; 159: 101-109
        • Purrucker J.C.
        • Haas K.
        • Rizos T.
        • et al.
        Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants.
        JAMA Neurol. 2016; 73: 169-177
        • Wilson D.
        • Charidimou A.
        • Shakeshaft C.
        • et al.
        Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.
        Neurology. 2016; 86: 360-366
        • Melmed K.R.
        • Lyden P.
        • Gellada N.
        • et al.
        Intracerebral hemorrhagic expansion occurs in patients using non-vitamin k antagonist oral anticoagulants comparable with patients using warfarin.
        J Stroke Cerebrovasc Dis. 2017; 26: 1874-1882
        • Beyer-Westendorf J.
        • Förster K.
        • Pannach S.
        • et al.
        Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry.
        Blood. 2014; 124: 955-962
        • Camm A.J.
        • Kirchhof P.
        • Lip G.Y.
        • et al.
        Guidelines for the management of atrial fibrillation: the task force for theManagement of atrial fibrillation of the European Society of Cardiology (ESC).
        Europace. 2010; 12: 1360-1420
        • Lip G.Y.
        • Nieuwlaat R.
        • Pisters R.
        • et al.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation.
        Chest. 2010; 137: 263-272
        • Gage B.F.
        • Waterman A.D.
        • Shannon W.
        • et al.
        Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation.
        JAMA. 2001; 285: 2864-2870
        • DA Graeb R.W.
        • Lapointe J.A.
        • Neugent R.A.
        • Harrison P.B.
        Computed tomographic diagnosis of intraventricular hemorrhage.
        Etiol Prognosis. Radiol. 1982; 143: 91-96
        • Czorlich P.
        • Ricklefs F.
        • Reitz M.
        • et al.
        Impact of intraventricular hemorrhage measured by Graeb and Leroux score on case fatality risk and chronic hydrocephalus in aneurysmal subarachnoid hemorrhage.
        Acta Neurochir. 2015; 157: 409-415
        • Kothari R.U.
        • Brott T.
        • Broderick J.P.
        • et al.
        The ABCs of measuring intracerebral hemorrhage volumes.
        Stroke. 1996; 27: 1304-1305
        • Webb A.J.
        • Ullman N.L.
        • Morgan T.C.
        • et al.
        MISTIE and clear investigators. accuracy of the ABC/2 score for intracerebral hemorrhage: systematic review and analysis of MISTIE, CLEAR-IVH, and clear III.
        Stroke. 2015; 46: 2470-2476
        • Dowlatshahi D.
        • Demchuk A.M.
        • Flaherty M.L.
        • Ali M.
        • Lyden P.L.
        • Smith E.E.
        • VISTA Collaboration
        Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes.
        Neurology. 2011; 76: 1238-1244
        • Dowlatshahi D.
        • Butcher K.S.
        • Asdaghi N.
        • et al.
        Canadian PCC Registry (CanPro) investigators. poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal.
        Stroke. 2012; 43: 1812-1817
        • Tetri S.
        • Juvela S.
        • Saloheimo P.
        • Pyhtinen J.
        • Hillbom M.
        Hypertension and diabetes as predictors of early death after spontaneous intracerebral hemorrhage.
        J Neurosurg. 2009; 110: 411-417
        • Sacco S.
        • Marini C.
        • Toni D.
        • Olivieri L.
        • Carolei A.
        Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry.
        Stroke. 2009; 40: 394-399
        • van Asch C.J.
        • Luitse M.J.
        • Rinkel G.J.
        • van der Tweel I.
        • Algra A.
        • Klijn C.J.
        Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.
        Lancet Neurol. 2010; 9: 167-176
        • Moradiya Y.
        • Murthy S.B.
        • San Luis C.O.
        • Modi S.
        • Naval N.
        Trends in inpatient mortality after ischemic and hemorrhagic strokes in the United States.
        Neuroepidemiology. 2014; 43: 269-271
        • Benjamin E.J.
        • Blaha M.J.
        • Chiuve S.E.
        • American Heart Association Statistics Committee and Stroke Statistics Subcommittee
        Heart disease and stroke statistics-2017 update: a report from the American Heart Association.
        Circulation. 2017; 135: e146-e603